These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27699734)

  • 21. Endometrial hyperplasia and endometrial cancer.
    Burke TW; Tortolero-Luna G; Malpica A; Baker VV; Whittaker L; Johnson E; Follen Mitchell M
    Obstet Gynecol Clin North Am; 1996 Jun; 23(2):411-56. PubMed ID: 8784886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ovarian preservation during treatment of early stage endometrial cancer].
    Poilblanc M; Samouelian V; Querleu D
    Bull Cancer; 2012 Jan; 99(1):61-8. PubMed ID: 22198406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prescription pattern of Chinese herbal products that contain dang-qui and risk of endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan: a population-based study.
    Wu CT; Lai JN; Tsai YT
    PLoS One; 2014; 9(12):e113887. PubMed ID: 25485843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of endometrial cancer in young women.
    Shah MM; Wright JD
    Clin Obstet Gynecol; 2011 Jun; 54(2):219-25. PubMed ID: 21508691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management options and fertility-preserving therapy for premenopausal endometrial hyperplasia and early-stage endometrial cancer.
    Gressel GM; Parkash V; Pal L
    Int J Gynaecol Obstet; 2015 Dec; 131(3):234-9. PubMed ID: 26384790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraoperative lymphatic mapping techniques for endometrial cancer.
    Mais V; Cirronis MG; Piras B; Silvetti E; Cossu E; Melis GB
    Expert Rev Anticancer Ther; 2011 Jan; 11(1):83-93. PubMed ID: 21166513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
    Brinton LA; Hoover RN
    Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progestogen deficiency and endometrial cancer risk.
    Schindler AE
    Maturitas; 2009 Apr; 62(4):334-7. PubMed ID: 19231117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound, hysteroscopy and endometrial biopsy in the investigation of endometrial cancer.
    Symonds I
    Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):381-91. PubMed ID: 11476560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
    Chang SC; Lacey JV; Brinton LA; Hartge P; Adams K; Mouw T; Carroll L; Hollenbeck A; Schatzkin A; Leitzmann MF
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):723-30. PubMed ID: 17416763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantity vs. quality: an exploration of the predictors of posttreatment sexual adjustment for women affected by early stage cervical and endometrial cancer.
    Juraskova I; Bonner C; Bell ML; Sharpe L; Robertson R; Butow P
    J Sex Med; 2012 Nov; 9(11):2952-60. PubMed ID: 22846510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: a clinical review.
    Tinelli A; Vergara D; Martignago R; Leo G; Malvasi A; Tinelli R
    Acta Obstet Gynecol Scand; 2008; 87(11):1101-13. PubMed ID: 18607816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The gynecological surveillance of women with Lynch syndrome in Sweden.
    Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
    Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abdominal obesity and endometrial cancer in egyptian females with postmenopausal bleeding.
    Zaki A; Gaber A; Ghanem E; Moemen M; Shehata G
    Nutr Cancer; 2011 Nov; 63(8):1272-8. PubMed ID: 22043928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Is it possible to screen for endometrial carcinoma? Incidence and risk factors].
    Broso PR; Giradi F
    Minerva Ginecol; 1995 Dec; 47(12):539-52. PubMed ID: 8720976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologic markers in endometrial cancer treatment.
    Engelsen IB; Akslen LA; Salvesen HB
    APMIS; 2009 Oct; 117(10):693-707. PubMed ID: 19775337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exogenous estrogens and endometrial carcinoma: review and comments for the clinician.
    Berger GS; Fowler WC
    J Reprod Med; 1977 Apr; 18(4):177-80. PubMed ID: 870690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diet, body size, physical activity, and the risk of endometrial cancer.
    Goodman MT; Hankin JH; Wilkens LR; Lyu LC; McDuffie K; Liu LQ; Kolonel LN
    Cancer Res; 1997 Nov; 57(22):5077-85. PubMed ID: 9371506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical parameters linked with malignancy in endometrial polyps.
    Gregoriou O; Konidaris S; Vrachnis N; Bakalianou K; Salakos N; Papadias K; Kondi-Pafiti A; Creatsas G
    Climacteric; 2009 Oct; 12(5):454-8. PubMed ID: 19591006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between tamoxifen use and high risk endometrial cancer histologic types.
    Bland AE; Calingaert B; Secord AA; Lee PS; Valea FA; Berchuck A; Soper JT; Havrilesky L
    Gynecol Oncol; 2009 Jan; 112(1):150-4. PubMed ID: 18937966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.